Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
4,531 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis.
Huang RS, Chow R, Benour A, et al. · Lancet Oncol · 2025Systematic Review, Meta-Analysis
- First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Petrelli F, Verri E, Ghidini A, et al. · JAMA Oncol · 2025Systematic Review, Meta-Analysis
- Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Haas NB, Powles TB, Tomczak P, et al. · Ann Oncol · 2026Clinical Trial, Phase III, Randomized Controlled Trial
- Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma.
Rini BI, Albiges L, Tang X, et al. · Ann Oncol · 2025Clinical Trial, Phase III, Randomized Controlled Trial
- Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis.
Moran M, Nickens D, Adcock K, et al. · Future Oncol · 2019Meta-Analysis, Systematic Review
- The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Zhang Y, Chen J, Liu H, et al. · Cancer Treat Rev · 2024Systematic Review, Meta-Analysis
- The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Tsuboi I, Matsukawa A, Kardoust Parizi M, et al. · Clin Genitourin Cancer · 2024Systematic Review, Meta-Analysis
- Circulating KIM-1 and survival outcomes in renal cell carcinoma: A systematic review and meta-analysis.
Lu J, Luo B, Xue C, et al. · Urol Oncol · 2026Systematic Review, Meta-Analysis
- Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysis.
Riveros C, Huang E, Ranganathan S, et al. · BJU Int · 2023Meta-Analysis, Systematic Review
- Intraoperative mannitol during robotic-assisted-laparoscopic partial nephrectomy.
Choi K, Hill S, Hale N, et al. · J Robot Surg · 2019Randomized Controlled Trial
- Eosinophilic Solid and Cystic Renal Cell Carcinoma-A Systematic Review and Meta-Analysis.
Loghin A, Popelea MC, Todea-Moga CD, et al. · Int J Mol Sci · 2024Systematic Review, Meta-Analysis
- Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Bui TO, Dao VT, Nguyen VT, et al. · Eur Urol · 2022Meta-Analysis, Research Support, Non-U.S. Gov't
- Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Duong NX, Le MK, Nguyen TT, et al. · Clin Genitourin Cancer · 2024Systematic Review, Meta-Analysis
- Trans-arterial embolization of renal cell carcinoma: a systematic review and meta-analysis.
Wright B, Johnson BS, Vassar M, et al. · Abdom Radiol (NY) · 2022Meta-Analysis, Systematic Review
- Selecting Patients with Small Renal Masses for Active Surveillance.
Johnson MH, Allaf ME, Pierorazio PM · Anticancer Agents Med Chem · 2018Systematic Review
- Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis.
Gu L, Peng C, Li H, et al. · Crit Rev Oncol Hematol · 2024Meta-Analysis, Systematic Review
- Systematic review and meta-analysis of preoperative imaging prediction of renal cell carcinoma tumour thrombus inferior vena cava wall invasion.
Smith RK, Navaratnam A, Vivian P · Clin Radiol · 2023Meta-Analysis, Systematic Review
- Systematic Review and Meta-Analysis of Clinical Outcomes after Enucleation of Pancreatic Metastases from Renal Cell Carcinoma.
Brozzetti S, Carati M, Sterpetti AV · Dig Surg · 2023Meta-Analysis, Systematic Review
- Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis.
Xu C, Geng H, Li Y, et al. · BMC Urol · 2024Meta-Analysis, Systematic Review
- Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
Singhal T, Singh P, Parida GK, et al. · Ann Nucl Med · 2024Meta-Analysis, Systematic Review
- Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Zacchi F, Merler S, Zampiva I, et al. · Oncologist · 2025Systematic Review, Meta-Analysis
- Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Yanagisawa T, Mori K, Matsukawa A, et al. · Cancer Immunol Immunother · 2024Systematic Review, Network Meta-Analysis
- Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Nunno VD, Mollica V, Gatto L, et al. · Immunotherapy · 2019Meta-Analysis, Systematic Review
- New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis.
Lombardi P, Filetti M, Falcone R, et al. · Cancer Treat Rev · 2022Systematic Review, Network Meta-Analysis
- Systematic review of renal carcinoma prognostic factors.
Lorente D, Trilla E, Meseguer A, et al. · Actas Urol Esp · 2017Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.